Micell Technologies Announces Presentation of Clinical Data a... ( DURHAM N.C. Nov. 2 2011 /- Micell Tec...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

Date:11/2/2011

DURHAM, N.C., Nov. 2, 2011 /PRNewswire/ -- Micell Technologies, Inc. today announced that it has completed a preliminary analysis of data from the first-in-human clinical study, DESSOLVE I, of the MiStent® Sirolimus Drug Eluting Coronary Stent System, a thin drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation that is designed for controlled drug release. Four, six and eight month data will be presented at the Transcatheter Cardiovascular Therapeutics Conference (TCT 2011) in San Francisco, CA.

The presentation will be given in a Scientific Session, "Next Generation Drug-Eluting Stents and Bioabsorbable Scaffolds: Session II - Representative DES with Bioresorbable Polymers," on Tuesday, November 8 at 12:15 p.m. PST. Results will be presented by John Ormiston, M.D., Interventional Cardiologist with the Auckland Heart Group and Medical Director at Mercy Angiography in Auckland, New Zealand. William Wijns, M.D., Interventional Cardiologist with the Cardiovascular Center, Aalst, Belgium, and John Ormiston, M.D. are principal investigators for the study.

In the DESSOLVE I clinical trial, the MiStent DES was used to treat 30 patients with de novo lesions in coronary arteries ranging in diameter from 2.5 to 3.5 mm and amenable to treatment with a maximum 23 mm length stent. The study was performed in five centers in New Zealand, Australia and Belgium. This trial focused on evaluating the efficacy of the MiStent DES, and examined three independent groups of 10 patients using angiography, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) at four, six and eight months to evaluate the rate of in-stent late lumen loss (LLL) and the extent of tissue coverage of the stent at each time point.

Micell Technologies currently is conducting a second trial of the MiStent DES, DESSOLVE II; a prospective, single-blind, unbalanced randomized, controlled, multicenter superiority trial in Europe, Austr
'/>"/>

SOURCE Micell Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Micell Technologies Enrolls First Patient in CE Mark DESSOLVE II Study of MiStent™ Drug-Eluting Coronary Stent (DES)
2. Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data
3. Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
8. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
9. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
10. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
11. Senesco Technologies Initiates Preclinical Studies for Cancer Target

Post Your Comments:

(Date:5/22/2013)... Mai 2013 Kepner-Tregoe (KT), das ... heute bekannt, dass der Veteran von 13 ... zum Hauptgeschäftsführer ernannt wurde. Geraghty,s Erfahrung umfasst ... er zahlreiche Führungspositionen bei Fertigungsunternehmen innehielt. Er ... der als Kepner-Tregoe Hauptgeschäftsführer gedient hat, in ...

(Date:5/22/2013)... -- STEPh, Inc., a full service medical communications company, ... site ( http://www.stephreports.com ) dedicated to investigational ... Reports STEPh Reports are comprehensive critical reviews ... Report assesses the competitive landscape by individual drug monograph, ... specific key issues. STEPh Reports are written by individuals ...

(Date:5/22/2013)... 22, 2013 Hemoglobin A1C levels increased ... Type 2 diabetes, while modest improvements in A1C ... and can lead to substantial healthcare cost savings, ... Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th ... sponsored by Valeritas, makers of the V-Go ® ...

Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3 Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6

[0] Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer [0] Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site [0] Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance

... 24, 2011 Cadence, Inc., a leading manufacturer of ... markets, announced yesterday that it will invest nearly $16 ... allow Cadence to expand its capabilities in the medical ... significant new business. "This major expansion ...

... 2011 For the fifth straight year, Elekta has ... Clinical Oncology (ASCO) Electronic Health Records (EHR) Lab, June ... will be Elekta,s MOSAIQ® Oncology Information System, the first ... under the federal government,s HITECH Act. MOSAIQ is fully ...

Cached Medicine Technology:Cadence, Inc. Announces Major Expansion 2 Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO Annual Meeting 2

Cadence, Inc. Announces Major Expansion Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO Annual Meeting

(Date:5/22/2013)... May 22, 2013 Diversity Focus and ... This! The performance promotes awareness that physical disabilities ... Handicap This! performance will be held Friday, June 14th ... auditorium. Tickets for Handicap This! can be purchased ... audiences measure the level to which their mind is ...

(Date:5/22/2013)... Scottsdale, AZ (PRWEB) May 22, 2013 ... spend the next year participating in an intensive startup ... deliver valuable products or services and create local jobs ... . , Each year the Edson initiative offers approximately ... funding, office space, mentorship and training to launch their ...

(Date:5/22/2013)... Michigan study challenges previous research that suggests umpire ... study, a collaboration between researchers at U-M and ... into the controversial argument over whether MLB umpires ... of the same race. It found little statistical ... associate professor of sport management at the U-M ...

(Date:5/22/2013)... Over the next two decades, the cost of treating ... than double, topping more than $180 billion a year, ... the increase: an aging population. The report, from the ... was published May 22 in the journal Stroke ... system," Dr. Bruce Ovbiagele, chairman of the department of ...

(Date:5/22/2013)... hospitals may be reaping enormous income for patients ... infections contracted in their intensive care units. , ... the American Journal of Medical Quality , ... develops an avoidable central line-associated bloodstream infection (CLABSI) ... than a similar infection-free patient. Moreover, hospitals earn ...

[0] Handicap This! Comes to Marion, Iowa [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] U-M study challenges notion that umpires call more strikes for pitchers of same race [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report [0] Hospitals profit when patients develop bloodstream infections

... -- Foster care boosts language development in young children who ... at more than 100 children who had lived in institutions ... foster homes when they were about 22 months old, while ... were compared to about 60 young children who lived in ...

... does not promote healing. This is the conclusion ... the current edition of Deutsches rzteblatt International ... In negative-pressure wound therapy (NPWT), wounds are covered ... pressure is applied using an electronically controlled pump. ...

... Radiation Research Institute (JASRI) have successfully produced a first ... 1.2 Angstroms. This light was created using SACLA, a ... RIKEN in February 2011 in Harima, Japan. SACLA (SPring-8 ... the structure of atoms and molecules at a level ...

... reduction in overall cancer death rates translates to the ... and 2007, according to the latest statistics from the ... and its companion consumer publication Cancer Facts & Figures ... of the population equally. A special section of the ...

... published today in the journal Child Development ... "gut sense" of numbers can lead to a mathematical ... This inaccurate number sense is just one cause of ... Dr. Michele Mazzocco of the Kennedy Krieger Institute. ...

... News) -- The roots of gray hair may lie in ... stem cells, the cells that make and store the pigments ... Using mouse models, researchers at NYU Langone Medical Center found ... may explain how these stem cells work together to produce ...

Cached Medicine News:Health News:Language Delays Seen in Kids in Institutions Beyond Age 2 2 Health News:First X-ray lasing of SACLA 2 Health News:American Cancer Society report finds continued progress in reducing cancer mortality 2 Health News:American Cancer Society report finds continued progress in reducing cancer mortality 3 Health News:American Cancer Society report finds continued progress in reducing cancer mortality 4 Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 2 Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 3 Health News:Mouse Study Uncovers the Roots of Gray Hair 2

Language Delays Seen in Kids in Institutions Beyond Age 2 No healing in a vacuum First X-ray lasing of SACLA American Cancer Society report finds continued progress in reducing cancer mortality Poor 'gut sense' of numbers contributes to persistent math difficulties Mouse Study Uncovers the Roots of Gray Hair

Fastest, easiest and least expensive method for measuring exophthalmos. By sighting at right angles, this device eliminates parallax and allows the clinician to measure the amount of protrusion or bu...

1-Day Acuvue brand contact lenses offer the healthiest, most convenient way to wear contact lenses. There's no lens care or messy solutions required, just wear them one day and throw them away....

PLX40s, 40 Watt Sealed CO2 Laser System....

... to quickly deliver up to 250 millijoules ... powerful single-pulse ablation. This type of high-energy ... and cleanest CO2 surgical laser available today. ... the independent adjustment of pulse energy and ...

Medicine Products:

Luedde Exophthalmometer 1-Day Acuvue 40 Watt Sealed CO2 Laser System UltraPulse SurgiTouch CO2 Laser System